Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs
Our study demonstrates that simultaneous inhibition of CDK4/6 and XPO1 induces senescence in liver cancer cells, making them susceptible to CRBN-based PROTAC drugs.
Discover more from reviewer4you.com
Subscribe to get the latest posts to your email.
